Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 40.58M | 23.23% |
| Gross profit | 18.94M | 3.36% |
| Net profit | -1.92M | 94.09% |
| EBITDA | -262.19K | 99.18% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €29.38M |
Number of shares | 645.72M |
52-week high/low | €0.15 - €0.0404 |
| Dividends | No |
Beta | 0.31 |
P/E ratio | -0.52 |
PEG ratio | -0.01 |
P/B ratio | 0.40 |
P/S ratio | 0.16 |
Company profile
ClouDr Group Limited, an investment holding company, provides supplies and software as a service (SaaS) to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for chronic condition management. It distributes hospital supplies, which include medical devices, such as blood glucose meters and vital sign monitors, glucose testing strips, and OTC and prescription drugs; and hospital and pharmacy SaaS and digital marketing services to pharmaceutical companies. The company also provides real time consultation, digital condition tracking, and online prescription and ordering services. ClouDr Group Limited was founded in 2014 and is headquartered in Hangzhou, China.
| Name | CLOUDR GROUP LTD |
| CEO | Ming Kuang |
| Headquarters | Hangzhou,
zh China |
| Website | |
| IPO | 07/06/2022 |
| Employees | 776 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Hkse | 9955.HK |
Frankfurt | H3L.F |
München | H3L.MU |
Düsseldorf | H3L.DU |